Other studies have also associated reduced PON1 expression with adverse lipid metabolism and recognized this as a risk factor for obesity, liver steatosis and its more severe subtype steatohepatitis [28–30]. Here, PON1 is linked to obesity due to melanocortin 4 receptor deficiency.